PET developer Positron of Houston has completed the due diligencephase of its planned acquisition of GE Medical Systems' PET business(SCAN 7/31/96). Positron said it is in the latter stages of securingfinancing for the deal, which it expects to have in
PET developer Positron of Houston has completed the due diligencephase of its planned acquisition of GE Medical Systems' PET business(SCAN 7/31/96). Positron said it is in the latter stages of securingfinancing for the deal, which it expects to have in place in fourto six weeks. The company said it hopes to close the deal by theend of this year, after shareholder approval is received.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.